Cortechs.ai's NeuroQuant PET automates amyloid scan quantification after winning FDA 510(k) clearance.
FDA clearance brings AI nodule planning and sharper navigation to J&J's Monarch…
GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how…
TCS launches an agentic AI hub that brings governed agents to clinical…
Kyowa Kirin adopts Benchling's AI R&D platform with Cognizant handling the rollout…
KT and Seoul National University Hospital team up on a shared AI…
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
MIT Technology Review argues AI agents need reasoning, not just more data,…
Stanford Medicine reports that benchmark tests cannot monitor real clinical LLM use,…
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
AI is poised to transform healthcare by addressing global challenges ranging from antimicrobial resistance to…
The two Canadian AI-driven healthtech startups have each raised over $10 million in Series A…
AI revenue cycle startup Candid Health triples valuation with $120M Series D round as healthcare…
Transformer models outperform traditional methods in predicting antidepressant response from electronic health records, advancing precision…
Healthcare leaders face a critical juncture as they embrace AI’s potential while confronting rising risks…
The FDA's new discussion paper proposes doctor-style competency testing for generative AI medical devices before…
AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing…
Aureka closes a $100M Series B to train biological foundation models for AI-driven drug discovery.